251 related articles for article (PubMed ID: 12819026)
1. Identification of novel cellular targets in biliary tract cancers using global gene expression technology.
Hansel DE; Rahman A; Hidalgo M; Thuluvath PJ; Lillemoe KD; Schulick R; Ku JL; Park JG; Miyazaki K; Ashfaq R; Wistuba II; Varma R; Hawthorne L; Geradts J; Argani P; Maitra A
Am J Pathol; 2003 Jul; 163(1):217-29. PubMed ID: 12819026
[TBL] [Abstract][Full Text] [Related]
2. Dual mitogen-activated protein kinase and epidermal growth factor receptor inhibition in biliary and pancreatic cancer.
Jimeno A; Rubio-Viqueira B; Amador ML; Grunwald V; Maitra A; Iacobuzio-Donahue C; Hidalgo M
Mol Cancer Ther; 2007 Mar; 6(3):1079-88. PubMed ID: 17363501
[TBL] [Abstract][Full Text] [Related]
3. Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays.
Swierczynski SL; Maitra A; Abraham SC; Iacobuzio-Donahue CA; Ashfaq R; Cameron JL; Schulick RD; Yeo CJ; Rahman A; Hinkle DA; Hruban RH; Argani P
Hum Pathol; 2004 Mar; 35(3):357-66. PubMed ID: 15017593
[TBL] [Abstract][Full Text] [Related]
4. Bile acid accelerates erbB2-induced pro-tumorigenic activities in biliary tract cancer.
Kitamura T; Srivastava J; DiGiovanni J; Kiguchi K
Mol Carcinog; 2015 Jun; 54(6):459-72. PubMed ID: 24839254
[TBL] [Abstract][Full Text] [Related]
5. Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas.
Lódi C; Szabó E; Holczbauer A; Batmunkh E; Szíjártó A; Kupcsulik P; Kovalszky I; Paku S; Illyés G; Kiss A; Schaff Z
Mod Pathol; 2006 Mar; 19(3):460-9. PubMed ID: 16439986
[TBL] [Abstract][Full Text] [Related]
6. Genetic detection for micrometastasis in lymph node of biliary tract carcinoma.
Okami J; Dohno K; Sakon M; Iwao K; Yamada T; Yamamoto H; Fujiwara Y; Nagano H; Umeshita K; Matsuura N; Nakamori S; Monden M
Clin Cancer Res; 2000 Jun; 6(6):2326-32. PubMed ID: 10873083
[TBL] [Abstract][Full Text] [Related]
7. Global expression analysis of well-differentiated pancreatic endocrine neoplasms using oligonucleotide microarrays.
Maitra A; Hansel DE; Argani P; Ashfaq R; Rahman A; Naji A; Deng S; Geradts J; Hawthorne L; House MG; Yeo CJ
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5988-95. PubMed ID: 14676124
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel tumor markers of pancreatic cancer using global gene expression technology.
Iacobuzio-Donahue CA; Maitra A; Shen-Ong GL; van Heek T; Ashfaq R; Meyer R; Walter K; Berg K; Hollingsworth MA; Cameron JL; Yeo CJ; Kern SE; Goggins M; Hruban RH
Am J Pathol; 2002 Apr; 160(4):1239-49. PubMed ID: 11943709
[TBL] [Abstract][Full Text] [Related]
9. E74-Like Factor 3 Is a Key Regulator of Epithelial Integrity and Immune Response Genes in Biliary Tract Cancer.
Suzuki M; Saito-Adachi M; Arai Y; Fujiwara Y; Takai E; Shibata S; Seki M; Rokutan H; Maeda D; Horie M; Suzuki Y; Shibata T; Kiyono T; Yachida S
Cancer Res; 2021 Jan; 81(2):489-500. PubMed ID: 33293429
[TBL] [Abstract][Full Text] [Related]
10. Effect of antisense DNMT3b gene eukaryotic expression plasmid on expression of the DNMT3b gene in human biliary tract carcinoma cells.
Zuo S; Dong JQ; Guo W; Liu MF; Xu LN; Luo J; Zou SQ
Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):123-8. PubMed ID: 16481298
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers.
Kojima M; Sudo H; Kawauchi J; Takizawa S; Kondou S; Nobumasa H; Ochiai A
PLoS One; 2015; 10(2):e0118220. PubMed ID: 25706130
[TBL] [Abstract][Full Text] [Related]
12. Global gene expression profile of nasopharyngeal carcinoma by laser capture microdissection and complementary DNA microarrays.
Sriuranpong V; Mutirangura A; Gillespie JW; Patel V; Amornphimoltham P; Molinolo AA; Kerekhanjanarong V; Supanakorn S; Supiyaphun P; Rangdaeng S; Voravud N; Gutkind JS
Clin Cancer Res; 2004 Aug; 10(15):4944-58. PubMed ID: 15297395
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.
Caca K; Feisthammel J; Klee K; Tannapfel A; Witzigmann H; Wittekind C; Mössner J; Berr F
Int J Cancer; 2002 Feb; 97(4):481-8. PubMed ID: 11802210
[TBL] [Abstract][Full Text] [Related]
14. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.
Iacobuzio-Donahue CA; Ashfaq R; Maitra A; Adsay NV; Shen-Ong GL; Berg K; Hollingsworth MA; Cameron JL; Yeo CJ; Kern SE; Goggins M; Hruban RH
Cancer Res; 2003 Dec; 63(24):8614-22. PubMed ID: 14695172
[TBL] [Abstract][Full Text] [Related]
15. Global gene profiling in human endometrium during the window of implantation.
Kao LC; Tulac S; Lobo S; Imani B; Yang JP; Germeyer A; Osteen K; Taylor RN; Lessey BA; Giudice LC
Endocrinology; 2002 Jun; 143(6):2119-38. PubMed ID: 12021176
[TBL] [Abstract][Full Text] [Related]
16. Identification of differentially expressed genes in clinically distinct groups of serous ovarian carcinomas using cDNA microarray.
Collins Y; Tan DF; Pejovic T; Mor G; Qian F; Rutherford T; Varma R; McQuaid D; Driscoll D; Jiang M; Deeb G; Lele S; Nowak N; Odunsi K
Int J Mol Med; 2004 Jul; 14(1):43-53. PubMed ID: 15202015
[TBL] [Abstract][Full Text] [Related]
17. Novel targeted approaches to treating biliary tract cancer: the dual epidermal growth factor receptor and ErbB-2 tyrosine kinase inhibitor NVP-AEE788 is more efficient than the epidermal growth factor receptor inhibitors gefitinib and erlotinib.
Wiedmann M; Feisthammel J; Blüthner T; Tannapfel A; Kamenz T; Kluge A; Mössner J; Caca K
Anticancer Drugs; 2006 Aug; 17(7):783-95. PubMed ID: 16926628
[TBL] [Abstract][Full Text] [Related]
18. Expression and clinicopathological significance of notch signaling and cell-fate genes in biliary tract cancer.
Mazur PK; Riener MO; Jochum W; Kristiansen G; Weber A; Schmid RM; Siveke JT
Am J Gastroenterol; 2012 Jan; 107(1):126-35. PubMed ID: 21931375
[TBL] [Abstract][Full Text] [Related]
19. Loss of Stk11/Lkb1 expression in pancreatic and biliary neoplasms.
Sahin F; Maitra A; Argani P; Sato N; Maehara N; Montgomery E; Goggins M; Hruban RH; Su GH
Mod Pathol; 2003 Jul; 16(7):686-91. PubMed ID: 12861065
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance of growth factors and their receptors as potential therapeutic targets for biliary tract carcinoma.
Ojima H
J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):319-25. PubMed ID: 22278347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
